Skyline Medical (NSDQ:SKLN) today announced plans to shift its moniker and brand to Precision Therapeutics, effective Feb. 1. The change is intended to reflect the company’s “new strategic focus on applying artificial intelligence to precision medicine and drug delivery,” the Minneapolis, Minn.-based company said. As part of the change, Precision Therapeutics will shift its NASDAQ ticker symbol […]
Skyline Medical prices $3m offering
Skyline Medical (NSDQ:SKLN) today priced an upcoming offering, looking to raise approximately $2.8 million. The Minneapolis, Minn.-based company said it will offer 2.9 million units at 95¢ per unit, with each unit consisting of 1 share of the company’s common stock and 0.3 of a Series E warrant. Each whole Series E warrant will allow for […]
Skyline Medical to take 20% stake in Helomics, license Illumina’s gene sequencing tech
Fresh from its purchase of a 20% stake in joint venture partner Helomics, Skyline Medical (NSDQ:SKLN) said today that it inked a deal to license the MiSeqDx next-generation sequencing technology from Illumina (NSDQ:ILMN). Yesterday Minneapolis-based Skyline said it agreed to buy a lump of convertible shares representing 20% of Helomics, in exchange for 1.1 million newly issued SKLN shares, which […]
7 medtech stories we missed this week: Nov. 17, 2017
From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Skyline Medical launches JV deal with Helomics Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. […]
Skyline Medical to explore CRO biz, nixes CytoBiosciences merger deal
Skyline Medical today revealed plans for joint ventures with Helomics and CytoBiosciences looking to to explore services in the contract research organization industry, adding that it canceled its pending merger with CytoBiosciences to focus on the JVs. The Minneapolis, Minn.-based company said that the expansion into the CRO field “represents a major opportunity for Skyline.” “Personalized […]
7 medtech stories we missed this week: Nov. 3, 2017
From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed […]
7 medtech stories we missed this week: Sept. 8, 2017
From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention. 1. BrainScope to develop pediatric traumatic brain injury assessment device BrainScope announced in a Sept. 7 press release that it will immediately start creating […]
Skyline Medical inks merger deal with CytoBioscience
Skyline Medical said yesterday it inked a merger transaction deal with privately held biomedical firm CytoBioscience. San Antonio, Texas-based CytoBioscience develops and produces devices used in human cell research and drug development, Skyline Medical said, and has collaborative partnerships with pharmaceutical companies and academic institutions. Eagan, Minn-based Skyline Medical said that CytoBioscience currently has a backlog […]
7 medtech stories we missed this week: Feb. 24, 2017
Several companies made distribution deals this week, while others received approval for their products. Here are 7 medtech stories we missed this week but were still worth mentioning. 1. Israel OKs E-Qure’s BST device for chronic wounds E-Qure Corp. announced this week that it received marketing approval for its Bio-electrical Signal Therapy Device (BST Device) from […]
Reverse split brings Skyline Medical back into NASDAQ’s good graces
Skyline Medical said today that it is once again in full compliance with the NASDAQ and will continue to be listed on the exchange. The Minneapolis, Minn.-based company said it received notice from the NASDAQ that it “the company has evidenced full compliance with all requirements for continued listing on The NASDAQ Capital Market,” according to a […]
Skyline Medical shareholders OK 3x share increase
Skyline Medical said today that its shareholders agreed to an amendment which would increase shares of common stock from 8 million to 24 million. The decision was made at a special meeting of stockholders which met yesterday, the Minneapolis-based company said. “We are grateful to our stockholders for voting in favor of providing Skyline with the option […]
